logo-loader
viewEquillium

Equillium 'excited' about data from three different Phase IB clinical studies in second half of 2020

Equillium Inc (NASDAQ:EQ) CEO Bruce Steel sat down with Proactive’s Christine Corrado at BIO CEO in New York. The San Diego-based biotechnology company is developing products for autoimmune and inflammatory disorders.

Quick facts: Equillium

Price: 2.8 USD

NASDAQ:EQ
Market: NASDAQ
Market Cap: $49.52 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

mCloud Technologies sees big opportunities in Europe and Middle East with...

mCloud Technologies (CVE:MCLD-OTCQB: MCLDF) President of UK and EMEA Nitin Kapoor joined Steve Darling from Proactive to discuss the company putting a big push towards opportunities they see in Europe and the Middle East for their AssetCare technology. Kapoor discusses those opportunities and...

31 minutes ago

2 min read